Cardiologist specializing in pulmonary hypertension at the University of Michigan, Loving mother, #PAH #CTEPH @umichmedicine @umichcvc
Joined March 2023
- Tweets38
- Following41
- Followers213
- Likes26
Vallerie McLaughlin retweeted
Looking fwd to working w ⭐️ colleagues @ Gateway to the #PulmonaryHypertension World Symposium #WSPH❗️
@SteveMathaiMD @SudarRajagopal #OksanaShlobin @mardigomberg @IoanaPreston @victor_moles @ValMcLaughlinMD @sonjabart @jeanlucvachiery @Viniciodjperez @SandeepSahayMD @yreddyhf
Ready to elevate your practice in Pulmonary Hypertension care? 🫁
Don't miss PH Update 2026 in Ann Arbor on Oct 2nd! Join top experts for cutting-edge insights & earn up to 7.0 CME/CNE/CPE credits.
Secure your spot now! 👇 web.cvent.com/event/94556718…
A message from @ValMcLaughlinMD:
vimeo.com/1199900969/a40530b…
@jeanlucvachiery @SandeepSahayMD @robertbadaglia1 @heresi_gustavo @anjalivaidyaMD @AlbertaPHdoc @OSitbon @yreddyhf @AssociationWsph @atscommunity @CHESTPulmCardio @PulmonaryNews @umichCVC @umichmedicine
Vallerie McLaughlin retweeted
Early bird registration fee for the meeting PH UPDATE 2026_Gateway to the 8th World Symposium that will take place in Ann Arbor (Michigan US) on October 2, 2026_ EXPIRES TOMORROW!
#WSPH #WSPHAssociation @victor_moles
web.cvent.com/event/94556718…
Vallerie McLaughlin retweeted
Ready to elevate your practice in Pulmonary Hypertension care? 🫁
Don't miss PH Update 2026 in Ann Arbor on Oct 2nd! Join top experts for cutting-edge insights & earn up to 7.0 CME/CNE/CPE credits.
Secure your spot now! 👇 web.cvent.com/event/94556718…
A message from @ValMcLaughlinMD:
vimeo.com/1199900969/a40530b…
@jeanlucvachiery @SandeepSahayMD @robertbadaglia1 @heresi_gustavo @anjalivaidyaMD @AlbertaPHdoc @OSitbon @yreddyhf @AssociationWsph @atscommunity @CHESTPulmCardio @PulmonaryNews @umichCVC @umichmedicine
Vallerie McLaughlin retweeted
Headline: Don't miss out on the PH Update 2026! 🗓️
Join us in Ann Arbor on Friday, October 2nd, for a comprehensive, full-day symposium serving as your official Gateway to the 8th World Symposium on Pulmonary Hypertension.
Whether you are a physician, nurse, or pharmacist, this is your opportunity to elevate your practice with the latest insights in PH management while earning valuable continuing education credits.
🔍 Event Highlights:
📍 Location: Sheraton Ann Arbor Hotel (Ann Arbor, MI)
🧠 Credits: Earn up to 7.0 CME / CNE / CPE credits
🎙️ Featuring: Global experts and cutting-edge clinical updates
Secure your spot today and stay ahead of the curve in pulmonary hypertension care.
👉 Register here: web.cvent.com/event/94556718…
#PHUpdate #WSPH @umichCVC @ValMcLaughlinMD @jeanlucvachiery @robertbadaglia1 @sonjabart @rchannick @heresi_gustavo @VIRkhaja @SteveMathaiMD @SandeepSahayMD @anjalivaidyaMD @AlbertaPHdoc @OSitbon @yreddyhf
Vallerie McLaughlin retweeted
Prescribing sotatercept alongside standard treatment for pulmonary arterial hypertension significantly reduces the likelihood of worsening disease when added within the first year after diagnosis, according to a new study in @NEJM led by @ValMcLaughlinMD: michiganmedicine.org/health-…
Vallerie McLaughlin retweeted
Full room packed at joint session of @escardio and @EuroRespSoc on modern management of pulmonary hypertension. Sotatercept, seralutynib, precision medicine and pulmonary artery denervation are currently hot topics in the field
#ESCCongress #PulmonaryHypertension @ValMcLaughlinMD
Vallerie McLaughlin retweeted
Wow! Great news for the #PAH community! The #ZENITH clinical trial meets primary endpoint at interim analysis and adds data supporting the use of #sotatercept. An immense honor to be part of this team. @ValMcLaughlinMD @umichCVC @umichmedicine
Vallerie McLaughlin retweeted
@OSitbon @ValMcLaughlinMD @JimWhiteCurePAH @AlbertaPHdoc @PHAssociation @ATS_PC @LancetRespirMed @CHESTPulmCardio
Finally out, numerous meetings, discussions for more than 2 years!! Thought provoking. Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients - ScienceDirect sciencedirect.com/science/ar…
Vallerie McLaughlin retweeted
Honored to present highlights from the 7th World Symposium on Pulmonary Hypertension today at the #AHA24 meeting in Chicago with this amazing panel @SudarRajagopal Brad Maron @WendyKChung Marc
Humbert @RaymondBenzaMD @MMukherjeeMD @ValMcLaughlinMD
Vallerie McLaughlin retweeted
Thanks to Sandeep Sahay, MD, MSc, ATSF, for his contribution to the September 1 issue
Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective
@SandeepSahayMD
@ValMcLaughlinMD
atsjournals.org/doi/full/10.…
Vallerie McLaughlin retweeted
Excellent experience while working on this with @ValMcLaughlinMD @IoanaPreston @nickhsk_phdoc @thenappanMD Chakinala @ATSBlueEditor @ATS_PC @atscommunity @PHAssociation
Contemporary Treatment of Pulmonary Arterial Hypertension: A US Perspective | American Journal of Respiratory and Critical Care Medicine | Articles in Press atsjournals.org/doi/10.1164/…
Vallerie McLaughlin retweeted
🚨 The #WSPH2024 is not yet over and the 2029 is already announced!! Last TF dinner with friends @ValMcLaughlinMD @OSitbon @victor_moles #Marc#Humbert @TomCascinoMD @Montanidavid @AssociationWsph
Vallerie McLaughlin retweeted
We did it! Thanks for the all members in TF10.
@SteveMathaiMD @ValMcLaughlinMD @OSitbon
#WSPH2024 @AssociationWsph
Vallerie McLaughlin retweeted
Just 1 week to go until #WSPH2024 to meet old and new with friends! Will you be there?
#WSPH2024 #WSPHAssociation #PAH
Vallerie McLaughlin retweeted
We are pleased to introduce you our Social Media Ambassadors!
They will share their own experience in real time during the Symposium. Follow them and #WSPH2024
@jeanlucvachiery
@TamCardio
@Montanidavid
@RyanTedfordMD
Vallerie McLaughlin retweeted
We're going to Barcelona! We look forward to bringing together experts in the science of PH, patients, caregivers, and all to our first ever global fun walk, the Let Me Be Your Lungs Unity Walk. Learn more at bit.ly/3RayakZ
Vallerie McLaughlin retweeted
The FDA has approved two new therapies for the treatment of #pulmonaryhypertension, Opsynvi and Winrevair. Learn the basics about pathways, side effects, and if this treatment could be a fit for you in our pre-recorded webinar.
bit.ly/4bz73rF
